Quotient BioResearch supports key industry trend with comprehensive biomarker services for drug development.

Quotient Bioresearch (Quotient) offers valuable know-how in marker development, the establishment and validation of methods, and routine quantification of close to 250 different biomarkers. The company has one of the largest and best equipped bioanalytical and biomarker facilities in Europe. Now, as a recent report confirms a 10-fold increase in clinical trials utilising biomarkers (2005 - 2009), and stories appear daily about the discovery of potential biomarkers, Quotient continues to lead the way by investing in new technology and the early adoption of new analytical platforms. Biomarkers can be correlated with …